Il 17/04/2023 ore 10.00 – 12.00.

“Crystalline purity and crystalline impurities in pharmaceuticals: pushing analytical boundaries using state-of-the-art instrumentation and methods”
A. Grandeury (Novartis Pharma AG) meets F. Gozzo (Excelsus Structural Solutions)
In the field of pharmaceutical development of New Chemical Entities, the design of the formulation needs to adapt to the physico-chemical properties of the active pharmaceutical ingredients, aiming to ensure appropriate safety, efficacy and performance along preclinical and clinical activities.The relevance of crystalline forms and crystalline purity against other …

Read More